ELESTAT

This brand name is authorized in United States. It is also authorized in Mexico.

Active ingredients

The drug ELESTAT contains one active pharmaceutical ingredient (API):

1	Epinastine UNII GFM415S5XL - EPINASTINE HYDROCHLORIDE
	Epinastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H1-receptor and has affinity for the histamine H2receptor. Epinastine also possesses affinity for the α1, α2, and 5-HT2–receptors.
	Read more about Epinastine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ELESTAT Ophthalmic solution	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GX10	Epinastine	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	086M
US	FDA, National Drug Code	0023-9201